A cohort study of the risk on infection-related hospitalization with different modalities of dialysis
-
摘要: 目的:探讨不同透析方式血液透析、腹膜透析患者感染相关住院风险的差异及其原因。方法:选取2009-01-2015-12我院透析期间生活习惯相同或相似的患者共500例,分为2组,其中腹膜透析250例、血液透析250例,采用回顾性病例调查手段,配对队列研究的方法。对2组患者住院率和住院天数、住院原因进行统计比较。结果:腹部感染及透析相关性感染是2组患者感染相关性住院的主要原因(PD:0.019/0.100,HD:0.017/0.041)。腹膜透析患者感染导致的年住院率约是血液透析患者2倍(0.15,0.09),腹膜透析患者感染相关性住院的风险是血液透析患者感染相关性住院风险的1.55倍,其中透析相关性感染、败血症感染、腹部感染及肌肉骨骼系统感染导致的住院风险,腹膜透析患者是血液透析患者的3.47倍、1.42倍、1.31倍及1.19倍。结论:腹膜透析更易导致患者感染相关性住院,增加了住院率。Abstract: Objective:Peritonitis is a common complication of peritoneal dialysis (PD),there is no report that the risk of infection-related hospitalization for patients undergoing PD is higher than hemodialysis (HD) patients.Method:A retrospective propensity matched-cohort of patients undergoing continuous dialysis between January 2004 and December 2007 were assembled,In all were 500 cases,among that peritoneal dialysis included 250 cases and hemodialysis included 250 cases.Result:The differences among the demographic characteristic,comorbid conditions,laboratory biochemical indicators between patients of PD and HD were no insignificance.The rate per person-year of infection-related hospitalization that the major reasons were abdominal and dialysis-related infection (PD:0.019/0.100,HD:0.017/0.041) for PD patients was nearly twice higher than HD patients (0.15,0.09).The hazard ratio of infection-related hospitalization for PD patients was 1.55 higher than HD patients,among that hazard ratio of infection-related hospitalization of dialysis-related,septicemia,abdominal and musculoskeletal for PD patients was independently 3.47 higher,1.42 higher,1.31 higher,1.19 higher than HD patients.Conclusion:PD is easier to lead to infecting-related hospitalization and highen the rate of hospitalization and the lethal,so the HD is the optimal choice for the end-stage renal diseases' patients.
-
Key words:
- dialysis /
- related-infection /
- influencing-factors /
- hospitalization
-
[1] Meguid El Nahas A,Bello A K.Chronic kidney disease:the global challenge[J].Lancet,2005,365(9456):331-340.
[2] Saran R,Li Y,Robinson B,et al.US Renal Data System 2014 Annual Data Report:Epidemiology of Kidney Disease in the United States[J].Am J Kidney Dis,2015,66(1Suppl 1):Svii,S1-305.
[3] Dalrymple L S,Johansen K L,Chertow G M,et al.Infection-related hospitalizations in older patients with ESRD[J].Am J Kidney Dis,2010,56(3):522-530.
[4] Dalrymple L S,Katz R,Kestenbaum B,et al.The risk of infection-related hospitalization with decreased kidney function[J].Am J Kidney Dis,2012,59(3):356-363.
[5] Collins A J,Foley R N,Chavers B,et al.United States Renal Data System 2011Annual Data Report:Atlas of chronic kidney disease&end-stage renal disease in the United States[J].Am J Kidney Dis,2012,59(1Suppl 1):A7,e1-420.
[6] Furumatsu Y,Nagasawa Y,Yamamoto R,et al.Specialist care and improved long-term survival of dialysis patients[J].Nephrol Dial Transplant,2010,25(6):1930-1935.
[7] Tattersall J,Martin-Malo A,Pedrini L,et al.EBPG guideline on dialysis strategies[J].Nephrol Dial Transplant,2007,22 Suppl 2:ii5-21.
[8] Kooman J,Basci A,Pizzarelli F,et al.EBPG guideline on haemodynamic instability[J].Nephrol Dial Transplant,2007,22 Suppl 2:ii22-44.
[9] Jahani F F,Ahmadnezhad E.Risk factor of peritonitis in peritoneal dialysis patient[J].International Journal of Infectious Diseases,2012,16(2):e218-e219.
[10] Unal A,Sipahioglu M H,Kocyigit I,et al.Risk factor(s)related to high membrane permeability in peritoneal dialysis[J].Renal Failure,2016,38(2):238-241.
[11] Dong J,Chen Y,Luo S,et al.Peritoneal protein leakage,systemic inflammation,and peritonitis risk in patients on peritoneal dialysis[J].Perit Dial Int,2013,33(3):273-279.
[12] 朱伟平,催彤霞,徐庆东,等.腹膜透析相关性腹膜炎的菌谱及其药敏分析[J].中国血液净化,2011,10(7):357-359.
[13] Mujais S.Microbiology and outcomes of peritonitis in North America[J].Kidney Int Suppl,2006,(103):s55-s62.
[14] Williams V R,Quinn R,Callery S,et al.The impact of treatment modality on infection-related hospitalization rates in peritoneal dialysis and hemodialysis patients[J].Perit Dial Int,2011,31(4):440-449.
[15] 余学清.腹膜透析治疗学[M].北京:科学技术出版社,2008:144-156.
[16] 郭群英,陈林,阳晓,等.腹膜透析相关感染性腹膜炎致病菌及菌谱变化-单个腹膜透析中心15年回顾分析[J].中华肾脏病杂志,2006,22(12):719-724.
[17] Davenport A.Peritonitis remains the major clinical complication of peritoneal dialysis:the London,UK,peritonitis audit 2002-2003[J].Perit Dial Int,2009,29(3):297-302.
[18] Leinig C E,Moraes T,Ribeiro S,et al.Predictive value of malnutrition markers for mortality in peritoneal dialysis patients[J].J Ren Nutr,2011,21(2):176-183.
[19] Shikino K,Suzuki S,Yokokawa D,et al.Dialysis-Related Spondyloarthropathy with Cervical Amyloidoma[J].Am J Med,2016.
[20] Mou S,Wang Q,Fang W,et al.Change in cardiovascular disease status in peritoneal dialysis patients:a 5-year single-center experience[J].Ren Fail,2012,34(1):28-34.
[21] Cerasola G,Nardi E,Palermo A,et al.Epidemiology and pathophysiology of left ventricular abnormalities in chronic kidney disease:a review[J].J Nephrol,2011,24(1):1-10.
[22] Su X,Zhang K,Guo F,et al.Ischemia-modified albumin,apredictive marker of major adverse cardiovascular events in continuous ambulatory peritoneal dialysis patients[J].Clin Biochem,2013,46(15):1410-1413.
[23] Blake P G,Suri R S.Dialysis:Peritoneal dialysis vs hemodialysis:time to end the debate?[J].Nat Rev Nephrol,2011,7(6):308-310.
计量
- 文章访问数: 52
- PDF下载数: 18
- 施引文献: 0